Pillstats
Rx only · Tablet · Oral

Abiraterone

Abiraterone Acetate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL02BX03
RxCUI (US)1100072
US makers3 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.615$1.23$1.84$2.46Dec 2025Apr 2026Jul 2026
$1.647
Latest avg · Jul 22, 2026
-20%
Since Dec 17, 2025
3
Active US suppliers
83%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2144276418542025 Q12025 Q22025 Q32025 Q42026 Q1
310
Rx · 2026 Q1
18K
Units dispensed
-58%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown4SUPPLYING
AvKAREunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.